Resolute Wealth Strategies’s AbbVie ABBV Stock Holding History

Resolute Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Buy	5,025 +72	+1%	+$16K	0.47%	36
2025 Q4	$1.13M	Buy	4,953 +2	+0%	+$456	0.5%	35
2025 Q3	$1.15M	Buy	4,951 +1	+0%	+$204	0.52%	33
2025 Q2	$919K	Buy	4,950 +2	+0%	+$372	0.49%	34
2025 Q1	$1.04M	Buy	4,948 +1,190	+32%	+$231K	0.58%	33
2024 Q4	$668K	Buy	3,758 +2	+0.1%	+$368	0.34%	44
2024 Q3	$742K	Buy	3,756 +2	+0.1%	+$373	0.39%	40
2024 Q2	$644K	Buy	3,754 +2	+0.1%	+$331	0.37%	41
2024 Q1	$683K	Buy	3,752 +2	+0.1%	+$345	0.41%	40
2023 Q4	$581K	Sell	3,750 -158	-4%	-$23K	0.39%	40
2023 Q3	$583K	Sell	3,908 -69	-2%	-$10.1K	0.44%	36
2023 Q2	$536K	Buy	3,977 +5	+0.1%	+$733	0.42%	42
2023 Q1	$633K	Buy	+3,972	New	+$607K	0.54%	34

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Resolute Wealth Strategies's ABBV Position: Q1 2026 in Review

Resolute Wealth Strategies increased its AbbVie (ABBV) stake by 1.5% in Q1 2026, buying an estimated $16K and bringing the position to 5,025 shares worth $1.09M. The position accounts for 0.47% of the portfolio, ranked #36.

Resolute Wealth Strategies first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.15M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Resolute Wealth Strategies held 5,025 shares of AbbVie worth $1.09M as of Q1 2026.
Resolute Wealth Strategies bought 72 AbbVie shares in Q1 2026, an estimated $16K.
AbbVie made up 0.47% of Resolute Wealth Strategies's portfolio in Q1 2026, its #36 holding.
Resolute Wealth Strategies first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
Resolute Wealth Strategies's AbbVie position peaked at $1.15M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Resolute Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.